Induction of cellualar dysfunction by 3-deoxyglucosome as a mechanism of uremic and diabetic complications

3-脱氧葡萄糖体诱导细胞功能障碍作为尿毒症和糖尿病并发症的机制

基本信息

  • 批准号:
    11470216
  • 负责人:
  • 金额:
    $ 9.41万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
  • 财政年份:
    1999
  • 资助国家:
    日本
  • 起止时间:
    1999 至 2000
  • 项目状态:
    已结题

项目摘要

To determine if 3-deoxyglucosone (3-DG) is involved in the formation of intracellular AGEs, we measured the erythrocyte levels of 3-DG and AGEs such as imidazolone and N^ε-carboxymethyllysine (CML) in hemodialysis (HD) patients with diabetes. Further, to determine if the polyol pathway is involved in the formation of erythrocyte 3-DG and AGEs, an aldose reductase inhibitor (ARI) was administered to these patients. The erythrocyte levels of 3-DG and AGEs are elevated in diabetic HD patients. The administration of ARI reduces the erythrocyte levels of 3-DG and AGEs, especially imidazolone, as well as sorbitol. Thus, 3-DG and AGEs, especially imidazolone, in the erythrocytes are produced mainly via the polyol pathway. ART may prevent diabetic and uremic complications associated with AGEsWe investigated the contribution of high glucose concentration versus the presence of glucose degradation products (GDP) on AGE formation in the peritoneal cavity. Furthermore, the activity of a single chamber bag continuous ambulatory peritoneal dialysis (CAPD) fluid to generate AGE was compared to two double chamber bag PD fluids. During the incubation of HSA with PD-fluids under conditions similar to those of CAPD, only a minor part of AGE formation, measured as CML, imidazolones and fluorescence, derives from high glucose concentration, whereas glucose degradation products, which are formed during heat sterilization are by far the more important glycation precursor. The use of double chamber bags reduces therefore AGE formation considerably. Thus, it can be suggested that also in vivo, double chamber bags can decrease AGE formation in the peritoneal cavity during CAPD.
为了确定3-脱氧葡萄糖醛酮(3-DG)是否参与细胞内AGEs的形成,我们测定了糖尿病血液透析(HD)患者红细胞内3-DG和AGEs如咪唑酮和N^ε-羧甲基赖氨酸(CML)的水平。此外,为了确定多元醇途径是否参与红细胞3-DG和AGEs的形成,对这些患者给予了醛糖还原酶抑制剂(ARI)。糖尿病HD患者红细胞3-DG和AGEs水平升高。ARI的给药降低了红细胞中3-DG和AGEs的水平,尤其是咪唑酮和山梨醇。因此,红细胞中的3-DG和AGEs,特别是咪唑酮,主要通过多元醇途径产生。ART可以预防与AGE相关的糖尿病和尿毒症并发症我们研究了高葡萄糖浓度与葡萄糖降解产物(GDP)对腹膜腔AGE形成的贡献。此外,比较了单腔袋持续性非卧床腹膜透析(CAPD)液与两种双腔袋PD液产生AGE的活性。在与CAPD相似的条件下,HSA与PD液体孵育期间,只有一小部分AGE形成(以CML、咪唑酮和荧光形式测量)来自高葡萄糖浓度,而在热灭菌期间形成的葡萄糖降解产物是迄今为止更重要的糖化前体。因此,双室袋的使用大大减少了AGE的形成。因此,可以表明,在体内,双腔袋也可以减少CAPD期间腹膜腔中AGE的形成。

项目成果

期刊论文数量(29)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Tsukushi S: "Increased erythrocyte 3-DG and AGEs in diabetic hemodialysis patients : Role of the polyol pathway."Kidney Int. 55. 1970-1976 (1999)
Tsukushi S:“糖尿病血液透析患者红细胞 3-DG 和 AGE 增加:多元醇途径的作用。”Kidney Int。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Takayama F: "Dialysis-related amyloidosis of the heart in long-term hemodialysis patients."Kidney Int. 59(Suppl78). S172-S176 (2001)
Takayama F:“长期血液透析患者中​​与透析相关的心脏淀粉样变性。”Kidney Int。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Niwa T: "3-Deoxyglucosone : Metabolism, analysis, biological activity and clinical implication."J Chromatogr. 731. 23-36 (1999)
Niwa T:“3-脱氧葡萄糖酮:代谢、分析、生物活性和临床意义。”J Chromatogr。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Niwa T: "3-Deoxyglucosone and AGEs in uremic complications : nactivation of glutathione peroxidase by 3-deoxyglucosone."Kidney Int. 59(Suppl78). S37-S41 (2001)
Niwa T:“尿毒症并发症中的 3-脱氧葡萄糖酮和 AGE:3-脱氧葡萄糖酮使谷胱甘肽过氧化物酶失活。”Kidney Int。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Takayama F: "Dialysis-related amyloidosis of the beart in long-term hemodialysis patients."Kidney Int. 59(Suppl78). S172-S176 (2000)
Takayama F:“长期血液透析患者中​​与透析相关的淀粉样变性。”Kidney Int。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NIWA Toshimitsu其他文献

NIWA Toshimitsu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NIWA Toshimitsu', 18)}}的其他基金

Identification of urate transporter, genetic analysis of renal hypouricemia and the development of anti-hyperuricemia drug
尿酸转运蛋白的鉴定、肾性低尿酸血症的基因分析及抗高尿酸血症药物的开发
  • 批准号:
    14370318
  • 财政年份:
    2002
  • 资助金额:
    $ 9.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Stimulating effect of indoxyl sulfate on progression of renal failure and development of an inhibitor of its production
硫酸吲哚酚对肾衰竭进展的刺激作用及其产生抑制剂的开发
  • 批准号:
    11557076
  • 财政年份:
    1999
  • 资助金额:
    $ 9.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Role of 3-deoxyglucosone in the pathogenesis of uremic and diabetic complications
3-脱氧葡萄糖醛酮在尿毒症和糖尿病并发症发病机制中的作用
  • 批准号:
    08457287
  • 财政年份:
    1996
  • 资助金额:
    $ 9.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mass spectrometric analysis of crosslinker of aging proteins formed by Maillard reaction
美拉德反应形成的老化蛋白交联剂的质谱分析
  • 批准号:
    04836009
  • 财政年份:
    1992
  • 资助金额:
    $ 9.41万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

The Role of CA8 in Hepatic Glucose Production and Its Prospect as Type 2 Diabetes Mellitus Treatment
CA8在肝葡萄糖生成中的作用及其治疗2型糖尿病的前景
  • 批准号:
    24K19287
  • 财政年份:
    2024
  • 资助金额:
    $ 9.41万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Community-based Preconception Lifestyle Intervention to prevent Gestational Diabetes Mellitus in Women living in India
以社区为基础的孕前生活方式干预,以预防印度妇女妊娠期糖尿病
  • 批准号:
    494564
  • 财政年份:
    2023
  • 资助金额:
    $ 9.41万
  • 项目类别:
    Operating Grants
Linoleic acid-derived oxylipin species and cognitive function in type 2 diabetes mellitus
亚油酸衍生的氧脂素种类与 2 型糖尿病的认知功能
  • 批准号:
    495437
  • 财政年份:
    2023
  • 资助金额:
    $ 9.41万
  • 项目类别:
Control mechanisms of lung adenocarcinoma by SGLT2 inhibitors for treating diabetes mellitus.
SGLT2抑制剂治疗糖尿病对肺腺癌的控制机制。
  • 批准号:
    23K08326
  • 财政年份:
    2023
  • 资助金额:
    $ 9.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Therapeutic efficacy of dapagliflozin, a selective inhibitor of sodium–glucose co-transporter type 2, for chronic heart failure in Japanese patients with type 2 diabetes mellitus
选择性钠抑制剂达格列净的治疗效果
  • 批准号:
    23K06224
  • 财政年份:
    2023
  • 资助金额:
    $ 9.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Pathophysiological analysis of the beta cell volume change elicited by pregnancy and gestational diabetes mellitus in Japanese pregnant women
日本孕妇妊娠和妊娠糖尿病引起的β细胞体积变化的病理生理学分析
  • 批准号:
    23K08020
  • 财政年份:
    2023
  • 资助金额:
    $ 9.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The role of CXCL10-CXCR3 axis in the compounding effects of diabetes mellitus in periodontitis
CXCL10-CXCR3轴在糖尿病牙周炎复合作用中的作用
  • 批准号:
    10740433
  • 财政年份:
    2023
  • 资助金额:
    $ 9.41万
  • 项目类别:
The Study of the Association between Gestational Diabetes Mellitus and Mental Health during Pregnancy in Japanese Women
日本女性妊娠期糖尿病与孕期心理健康关系的研究
  • 批准号:
    23K10101
  • 财政年份:
    2023
  • 资助金额:
    $ 9.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Personalized diet therapy useful for glycemic control and quality of life in patients with type 1 diabetes mellitus
个性化饮食疗法有助于 1 型糖尿病患者的血糖控制和生活质量
  • 批准号:
    23K10809
  • 财政年份:
    2023
  • 资助金额:
    $ 9.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidating the Pathophysiology of Gestational Diabetes Mellitus
阐明妊娠糖尿病的病理生理学
  • 批准号:
    10738361
  • 财政年份:
    2023
  • 资助金额:
    $ 9.41万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了